
Dr Peter Chang is a cardiac and vascular specialist at Mount Elizabeth Hospital, Singapore.
He has experience in diagnosing, treating and preventing cardiac and vascular conditions. His clinical interests include high blood pressure, cholesterol disorders, coronary artery disease and heart rhythm disorders, as well as vascular conditions such as peripheral artery disease and venous disorders. He performs a range of diagnostic and minimally invasive procedures to help assess and manage circulation problems.
Dr Chang also has a special interest in conditions affecting the blood vessels and has extensive experience in performing endovascular procedures involving both arteries and veins.
Before joining private practice, he served as a senior consultant cardiologist at the National University Hospital (NUH), where he led the vascular medicine service and the vascular ultrasound imaging centre. He was also a director of the diagnostic vascular laboratory at the National University Heart Centre, Singapore, and headed the vein service at Alexandra Hospital.
Dr Chang graduated from the University of Hawaii, John A Burns School of Medicine, USA. Prior to coming to Singapore, he worked as a hospital-based medical specialist and a basic science researcher on immunotherapy at the University of California San Francisco, USA. He completed his cardiology fellowship at NUH and was awarded the Academic Medicine Development Award for further training at Stanford University, USA. Most recently, he was awarded a sabbatical to train in peripheral vascular interventions at the National Taiwan University Hospital, Taiwan.
He has been practising medicine for more than 20 years, and has performed more than 1,000 cases of endovascular and endovenous interventions.
He is a fellow of the several organisations including the Academy of Medicine, Singapore, the Asian Pacific Society of Interventional Cardiology and the American College of Cardiology.
He has been involved in research and education including as an assistant professor at Yong Loo Lin School of Medicine. He also regularly participates in international medical conferences and training workshops.
Dr Chang is a recipient of the Hospital Quality Improvement Project Winner.
Teo, T. W., Tan, S. M. L., Chiang, Y. Y., Oh, J. R., Chan, S. P., Kuntjoro, I., Low, T., Chang, P., Ong, J. H. A., Loh, P. H., Sim, H. W., Djohan, A. H., Cherian, R., Yap, E. S., Chee, Y. L., Kojodjojo, P., & Lim, Y. (2025). Impact of mechanical pulmonary thrombectomy for intermediate-risk pulmonary embolism: Results from a prospective multicenter, multi-ethnic Asian registry. Thrombosis Research, 251, 109357.
Kojodjojo, P., Ong, H. A., Loh, P. H., Tay, E., Chang, P., Kuntjoro, I., Low, T. T., & Lim, Y. (2023). First use of large-bore suction thrombectomy for acute pulmonary embolism in Asia-Pacific: feasibility and short-term clinical outcomes. Journal of Thrombosis and Thrombolysis, 55(4), 660–666.
See, R.M., Yao, Teo, Y.N., Teo, Y.H., Syn, N., Yip, A., Leong, S., Wee, C.F., Cheong J.Y., Lee, C.H., Chan, Y.Y., Yeo, T.C., Wong, C.C., Chang, P., Hong, C.C., Chai, P., Sia, C.H. (2022). Effect of Sodium-Glucose contransporter 2 on amputation Events: A Systematic Review and Meta-Analysis of Randomized-Controlled trials. Pharmacology, 107(3-4):123-130.
Tan, P.Z., Chew, N.W.S., Tay, S.H., Chang, P. (2021). The allergic myocardial infarction dilemma: Is it the anaphylaxis or the epinephrine? Journal of Thrombosis and Thrombolysis. Vol. 52, 941–948.